MAY2016-08-01
|
CP-CTNet_CLO-Mayo Clinic
|
A Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
MAY2017-09-01
|
CP-CTNet_CLO-Mayo Clinic
|
Phase I Double-Blind, Placebo-Controlled Trial of 27 mg Dolcanatide (SP-333) to Demonstrate Colorectal Bioactivity in Healthy Volunteers
|
Cancer Prevention and Control CIRB
|
Completed
|
|
MDA20-01-01
|
CP-CTNet_CLO-MD Anderson
|
A Phase IIa, Placebo-Controlled, Randomized Study of Daily Obeticholic Acid (OCA) to Reduce Intestinal Polyp Burden in Familial Adenomatous Polyposis (FAP)
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
MDA20-02-01
|
CP-CTNet_CLO-MD Anderson
|
Time Restricted Eating And Metformin (TEAM) in Invasive Breast Cancer (IBC) or Ductal Carcinoma in Situ (DCIS). A randomized, Phase IIb, Window of Opportunity Presurgical Trial.
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
MDA2013-02-02
|
CP-CTNet_CLO-MD Anderson
|
Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication of Barrett’s Esophagus with Radiofrequency Ablation
|
Cancer Prevention and Control CIRB
|
Completed
|
|
MDA2014-04-01
|
CP-CTNet_CLO-MD Anderson
|
Alternative Dosing of Exemestane in Postmenopausal Women with Stage 0-II ER-Positive Breast Cancer: a Randomized Presurgical Trial
|
Cancer Prevention and Control CIRB
|
Completed
|
|
MDA2014-04-02
|
CP-CTNet_CLO-MD Anderson
|
VADIS Trial: Phase II trial of Nelipepimut-S Peptide Vaccine in Women with DCIS of the Breast
|
Cancer Prevention and Control CIRB
|
Completed
|
|
MDA2016-07-02
|
CP-CTNet_CLO-MD Anderson
|
A Randomized, Double-blind, Placebo-controlled Study of 4-hydroxytamoxifen Topical Gel in Women with Mammographically Dense Breast
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
MDA2016-08-02
|
CP-CTNet_CLO-MD Anderson
|
A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer
|
Cancer Prevention and Control CIRB
|
Completed
|
|
MDA2017-09-03
|
CP-CTNet_CLO-MD Anderson
|
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers scheduled for Risk-reducing Salpingooophorectomy
|
Cancer Prevention and Control CIRB
|
Completed
|
|